BTIG analyst Matthew Vliet downgrades Zoom Video Comms (NASDAQ:ZM) from Buy to Neutral.
HC Wainwright & Co. Maintains Buy on Talaris Therapeutics, Lowers Price Target to $12
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Talaris Therapeutics (NASDAQ:TALS) with a Buy and lowers the price target from $18 to $12.